Based on the Anthem Inc stock forecast from 0 analysts, the average analyst target price for Anthem Inc is not available over the next 12 months. Anthem Inc’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of Anthem Inc is Slightly Bullish , which is based on 8 positive signals and 5 negative signals. At the last closing, Anthem Inc’s stock price was EUR 491.40. Anthem Inc’s stock price has changed by +0.68% over the past week, +0.51% over the past month and +18.70% over the last year.
No recent analyst target price found for Anthem Inc
No recent average analyst rating found for Anthem Inc
Company Overview Anthem Inc
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana. Read Less
Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to ...Read More
Frequently Asked Questions About Anthem Inc (A58:F) Stock
Stock Target Advisor's fundamental analysis for Anthem Inc's stock is Slightly Bullish .
A58:F stock's dividend yield is 1.23%.
Our analysis grades A58:F stock's dividend yield at F. This means that A58:F stock's dividend yield is above 50% of the stocks in the Healthcare Plans sector in the F exchange.
Based on this A58:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on A58:F's stock to indicate what its average analyst target is.
A58:F stock's Price/Earning ratio is 19.05.
Our analysis grades A58:F stock's Price / Earning ratio at F. This means that A58:F stock's Price/Earning ratio is above 50% of the stocks in the Healthcare Plans sector in the F exchange.
Based on this A58:F may be fairly valued for its sector
The last closing price of A58:F's stock was EUR 491.40.
The most recent market capitalization for A58:F is EUR 113.60B.
Unfortunately we do not have enough analyst data on A58:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Anthem Inc's stock.
As per our most recent records Anthem Inc has 104,900 Employees.
Anthem Inc's registered address is 220 Virginia Avenue, Indianapolis, IN, United States, 46204.
You can get more information about it from Anthem Inc's website at https://www.elevancehealth.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
Low debt
The company is less leveraged than its peers ,, and is among the top quartile, which makes it more flexible. However, do check the news and look at its sector. Sometimes this is low because the company is not growing and has no growth potential.
Low volatility
The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.
Superior risk adjusted returns
This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.
Positive cash flow
The company had positive total cash flow in the most recent four quarters.
Superior return on assets
The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.
High market capitalization
This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.
High dividend returns
The stock has outperformed its sector peers on average annual dividend returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile. This can be a good buy, especially if it is outperforming on total return basis , for investors seeking high income yields.
Superior return on equity
The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
Overpriced compared to earnings
The stock is trading high compared to its peers on a price to earning basis and is above the sector median.
Below median total returns
The company has under performed its peers on annual average total returns in the past 5 years.
Overpriced on cashflow basis
The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Anthem Inc (A58:F) Stock
Stock Target Advisor's fundamental analysis for Anthem Inc's stock is Slightly Bullish .
A58:F stock's dividend yield is 1.23%.
Our analysis grades A58:F stock's dividend yield at F. This means that A58:F stock's dividend yield is above 50% of the stocks in the Healthcare Plans sector in the F exchange.
Based on this A58:F may be a average dividend stock for its sector.
Unfortunately we do not have enough data on A58:F's stock to indicate what its average analyst target is.
A58:F stock's Price/Earning ratio is 19.05.
Our analysis grades A58:F stock's Price / Earning ratio at F. This means that A58:F stock's Price/Earning ratio is above 50% of the stocks in the Healthcare Plans sector in the F exchange.
Based on this A58:F may be fairly valued for its sector
The last closing price of A58:F's stock was EUR 491.40.
The most recent market capitalization for A58:F is EUR 113.60B.
Unfortunately we do not have enough analyst data on A58:F's stock to indicate whether its price will go up or not.
We can't find any ETFs which contains Anthem Inc's stock.
As per our most recent records Anthem Inc has 104,900 Employees.
Anthem Inc's registered address is 220 Virginia Avenue, Indianapolis, IN, United States, 46204.
You can get more information about it from Anthem Inc's website at https://www.elevancehealth.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for A58:F !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
